Skip to content
Screener

Elanco Animal Health Inc. ELAN Investing Cash Flow

Investing Cash Flow at other companies

Merck & Co. logo
Merck & Co.MRK
-$10.21B-587%
Phibro Animal Health logo
Phibro Animal HealthPAHC
-$16.81M+7.9%
Zoetis logo
ZoetisZTS
-$300M-41.5%
Neogen logo
NeogenNEOG
$97.73M+390%
Tractor Supply Company logo
Tractor Supply CompanyTSCO
-$324.28M-72.8%
Central Garden & Pet Company logo
Central Garden & Pet CompanyCENT
-$10.5M+2.6%

Other financials

Income statement

See full
Revenue$1.4B+10.2%
Gross profit$798.0M+11.9%
Net income$54.0M+391%
EPS (diluted)$0.11+450%

Balance sheet

See full
Cash & equivalents$530.0M-1.7%
Total debt$4.2B-6.2%
Total equity$6.6B-2.8%
Total assets$13.6B-1.3%

Cash flow

See full
Operating cash flow$277.0M+16.9%
CapEx$33.0M-42.1%
Free cash flow$244.0M+35.6%

Valuation

See full
Market cap$13.1B+89.0%
Enterprise value$16.81B+54.0%
P/S2.6×+1.1×

Profitability

See full
Gross margin55.4%+0.6pp
Net margin-4%-13.8pp
FCF margin7.5%-0.5pp

Returns & leverage

See full
Return on equity-3%-9.9pp
Debt / equity0.6×0.0×
Current ratio2.1×-0.5×

Where this comes from

Reported directly by Elanco Animal Health Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: Elanco Animal Health Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 9:06 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001739104-26-000043
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Cash paid for acquisitions, net of cash acquired(76)
Proceeds from divestitures9
Other investing activities, net(10)(1)
Net Cash Used for Investing Activities(170)(114)
Cash Flows from Financing Activities
Proceeds from Revolving Credit Facility125
Repayments of Revolving Credit Facility(125)
Proceeds from Securitization Facility50125

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Elanco Animal Health Inc.'s investing cash flow?
Elanco Animal Health Inc. (ELAN) reported investing cash flow of -$110M in Q2 2026.
How has Elanco Animal Health Inc.'s investing cash flow changed year-over-year?
Elanco Animal Health Inc.'s investing cash flow decreased by 96.4% year-over-year, from -$56M to -$110M.
What is the long-term trend for Elanco Animal Health Inc.'s investing cash flow?
Over 3 years (2021 to 2025), Elanco Animal Health Inc.'s investing cash flow has grown at a -19.3% compound annual growth rate (CAGR), from -$530M to -$279M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about Elanco Animal Health Inc.'s investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude